Short answer
Cooper Companies (The) (COO) filed its Q2 2025 10-Q quarterly report on May 30, 2025 for the quarter ended Apr 30, 2025. Quarterly revenue was $1.0B (up 6.3% year over year) with net income of $88M.
Q2 2025 key financials · XBRL
- Revenue
- $1.0B
- +6.3% YoY · +3.9% QoQ
- Net income
- $88M
- −1.3% YoY · −15.9% QoQ
- Operating margin
- 18.4%
- Gross margin
- 67.8%
- EPS (diluted)
- $0.44
- +0.0% YoY · −15.4% QoQ
Source: XBRL data from the Cooper Companies (The) (COO) Q2 2025 10-Q on SEC EDGAR. USD.
Cooper Companies (The) Q2 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No newly added risk factors disclosed in this quarter's 10-Q versus prior 10-K
- Most materially updated risk: increased focus on silicone hydrogel and single-use contact lenses due to market shift and growth in preferred modalities
- Regulatory risk: FDA approval for MiSight 1 day lens as first myopia management product for children aged 8-12, plus NMPA approval in China
- Operational risk: reliance on continued technological innovation and patent protection to maintain competitive position in fertility and eye care markets
- Market risk: intensified competition impacted by product quality, technological advances, price, and customer service responsiveness in fertility and women's health sectors
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Cooper Companies (The) quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.